Whole Life Replacement With a Policy Loan and Substandard Health
Daniel, 47, owns 60% of a regional HVAC contractor. He has a $500,000 whole life policy issued 14 years ago with a $120,000 cash value and an $85,000 outstanding policy loan at a 6% variable rate. The annual premium is $9,800. Eighteen months ago he was diagnosed with stage IA melanoma treated by wide excision; surveillance scans are clean and his oncologist projects no further treatment. A brokerage proposes a 1035 exchange into a $1,000,000 guaranteed universal life policy at $14,200 annually, rated Table 2. Daniel's buy-sell agreement with his partner requires $1,000,000 of coverage and is currently funded only by this policy. His wife earns $95,000, two children are in college, and the business line of credit is priced at 9.5%. Daniel asks whether he should exchange, keep the old policy, or do something else.
1. Identify the factors that should drive the keep-versus-exchange decision, and explain how Daniel's health history changes the analysis.
Read the worked answer
The decision is not a simple premium comparison. Relevant factors include:
- Need and amount: The buy-sell requires $1,000,000, but the existing policy provides only $500,000. The gap must be filled either by a new policy or by layering additional coverage.
- Cost of the loan: The $85,000 loan costs about $5,100 per year in interest. If unpaid, it capitalizes and erodes cash value and death benefit, and can eventually lapse the policy.
- Guarantees: A 14-year-old whole life policy was priced on an older mortality and interest basis. Surrendering it discards those guarantees and may trigger surrender charges.
- Insurability: The melanoma history makes Daniel a substandard risk today. A Table 2 offer is usable, but future applications may be rated higher or declined if surveillance findings change. That argues for locking in coverage now rather than waiting.
- New-policy risks: The new contract restarts the contestability and suicide periods and may have fewer guarantees if it is a minimally funded GUL.
A layered approach is often superior: keep the existing $500,000 policy and apply for an additional $500,000 of coverage. The exchange should be compared against that alternative, not against doing nothing.
2. Explain the tax mechanics of exchanging a policy that has an outstanding loan, including basis and modified endowment contract risk.
Read the worked answer
Section 1035 treatment makes a life-to-life exchange tax-deferred, but the loan complicates it. Daniel is relieved of an $85,000 debt, and that relief is generally treated as a distribution. Gain, if any, is measured against his basis. His basis is approximately premiums paid, about $9,800 × 14 = $137,000, less any prior withdrawals or untaxed distributions. Because the $120,000 cash value is below that estimated basis, the loan relief likely produces no taxable gain, but the new policy's basis is reduced by the amount of the loan and any boot.
The new contract must also be tested under the 7-pay limit. A $14,200 premium on a $1,000,000 death benefit is about 1.4% of the face amount and is unlikely to make the policy a modified endowment contract, but the test must be run using the actual guaranteed elements and any cash value transferred. If it is a MEC, loans and withdrawals are taxed as income first and may incur a 10% penalty before age 59½. The loan interest is not deductible. Daniel should not sign the exchange until the new insurer confirms in writing how the loan will be handled and whether the contract is MEC-free.
3. Recommend a course of action and identify the implementation steps and risks.
Read the worked answer
Recommendation: do not surrender or exchange the existing policy yet. First apply for an additional $500,000 of guaranteed universal life or convertible term coverage with full underwriting. If the offer is Table 2 or better, compare the all-in cost of layering new coverage against exchanging. Layering preserves the older policy's guarantees and cash value while satisfying the $1,000,000 buy-sell requirement.
Implementation steps:
- Stop loan growth by paying interest currently or amortizing the loan.
- Complete the new application and obtain the formal offer before touching the old policy.
- If the new policy is issued, coordinate ownership and beneficiary with the buy-sell; consider an ILIT for estate inclusion.
- Amend the buy-sell to identify both policies, the valuation method, and the funding obligation.
- Revisit annually, especially if melanoma surveillance changes.
Key risks: a decline or higher rating on the new policy, a lapse caused by loan capitalization, and a buy-sell that is underfunded during underwriting. The old policy should remain in force until the new coverage is delivered and the free-look period has passed.